Codexis (CDXS)- VIVO Ventures VII, LLC, a 10% owner, sold 86,894 shares in two separate transactions. VIVO Ventures sold 50,000 shares at $4.27; and 36,894 shares at $4.21. VIVO Ventures still owns 115,321 shares of CDXS.
Atara Biotherapeutics (ATRA)- Christopher Haqq, Chief Medical Officer, sold 1,346 shares at $22.32. Haqq still owns 293,948 shares of ATRA. Gad Soffer, COO, sold 5,356 shares at $22.41. Soffer still owns 145,249 shares of ATRA.
Pacira Pharmaceuticals (PCRX)- David M. Stack, CEO and Chairman, sold 15,000 shares at $45.32. The total value of the transaction was $679,800. Stack still owns 33,637 shares of PCRX. James S. Scibetta, President, sold 25,000 shares at $45.21. The total value of the transaction was approximately $1.13 million. Scibetta still owns 27,084 shares of PCRX.
Alder Biopharmaceuticals (ALDR)- Jeffrey T L Smith, Sr. VP Translational Medicine, sold 3,000 shares at $31.17. The total value of the transaction was $93,512. Smith does not own any shares of ALDR.
Eagle Pharmaceuticals (EGRX)- ProQuest Investments IV, L.P., a 10% owner, sold 99,795 shares in three separate transactions. ProQuest sold 24,949 shares at $60.77; 60,150 shares at $61.67; and 14,696 shares at $61.08. ProQuest still owns 5,387 shares of EGRX.
Jazz Pharmaceuticals (JAZZ)- Rick E. Winningham, Director, sold 633 shares at $136.45. The total value of the transaction was $86,373. Winningham still owns 15,391 shares of JAZZ.